SOPHiA GENETICS S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SOPH research report →
Companywww.sophiagenetics.com
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide.
- CEO
- Jurgi Camblong
- IPO
- 2021
- Employees
- 423
- HQ
- Rolle, CH
Price Chart
Valuation
- Market Cap
- $349.03M
- P/E
- -4.28
- P/S
- 4.30
- P/B
- 7.58
- EV/EBITDA
- -5.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 67.28%
- Op Margin
- -88.39%
- Net Margin
- -99.70%
- ROE
- -140.63%
- ROIC
- -63.43%
Growth & Income
- Revenue
- $77.27M · 18.56%
- Net Income
- $-78,999,000 · -26.41%
- EPS
- $-1.17 · -23.16%
- Op Income
- $-70,925,000
- FCF YoY
- 24.34%
Performance & Tape
- 52W High
- $5.70
- 52W Low
- $2.59
- 50D MA
- $4.92
- 200D MA
- $4.48
- Beta
- 1.01
- Avg Volume
- 103.62K
Get TickerSpark's AI analysis on SOPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 26 | Muken Ross | sell | 761 |
| May 19, 26 | Xu Zhenyu | sell | 608 |
| May 19, 26 | Camblong Jurgi | sell | 4,486 |
| May 19, 26 | Menu Philippe | sell | 608 |
| May 19, 26 | Van Well Daan | sell | 684 |
| May 19, 26 | Valente Manuela | sell | 380 |
| May 19, 26 | Puylaert Kevin | sell | 33 |
| May 13, 26 | Xu Zhenyu | sell | 4,000 |
| May 12, 26 | HIBBS KATHY L | sell | 7,508 |
| May 12, 26 | Menu Philippe | sell | 5,000 |
Our SOPH Coverage
We haven't published any research on SOPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SOPH Report →